Personal information

Other IDs

Scopus Author ID: 57208314728
SciProfiles: 2500862

Activities

Collapse all

Professional activities (3)

National Institutes of Health: Bethesda, Maryland, US

IRTA Research Fellow (Vaccine Research Center )
Membership
Source: Self-asserted source
Edward K. Sarfo

International AIDS Society: Geneva, CH

Membership
Source: Self-asserted source
Edward K. Sarfo

Icahn School of Medicine at Mount Sinai: New York, New York, US

Membership
Source: Self-asserted source
Edward K. Sarfo

Works (12)

Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability

Nature Communications
2024 | Journal article
DOI: 10.1038/s41467-023-44534-y
EID:

2-s2.0-85181446489

Part of ISSN: 20411723
Contributors: Gorman, J.; Cheung, C.S.-F.; Duan, Z.; Ou, L.; Wang, M.; Chen, X.; Cheng, C.; Biju, A.; Sun, Y.; Wang, P. et al.
Source: Self-asserted source
Edward K. Sarfo via Scopus - Elsevier

Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization.

Journal of virology
2023-04-26 | Journal article
DOI: 10.1128/jvi.01604-22
PMID: 37098956
Contributors: Sastry M; Changela A; Gorman J; Xu K; Chuang GY; Shen CH; Cheng C; Geng H; O'Dell S; Ou L et al.
Source: Self-asserted source
Edward K. Sarfo
grade
Preferred source (of 2)‎

Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1

Vaccines
2022-11 | Journal article | Author
DOI: 10.3390/vaccines10111916
Contributors: Li Ou; Krishana Gulla; Andrea Biju; Daniel W. Biner; Tatsiana Bylund; Anita Changela; Steven J. Chen; Cheng-Yan Zheng; Nicole Cibelli; Angela R. Corrigan et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial

eClinicalMedicine
2022-06 | Journal article
DOI: 10.1016/j.eclinm.2022.101477
Contributors: Katherine V. Houser; Martin R. Gaudinski; Myra Happe; Sandeep Narpala; Raffaello Verardi; Edward K. Sarfo; Angela R. Corrigan; Richard Wu; Ro Shauna Rothwell; Laura Novik et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques

Nature Medicine
2021 | Journal article
DOI: 10.1038/s41591-021-01574-5
EID:

2-s2.0-85120949616

Part of ISSN: 1546170X 10788956
Contributors: Zhang, P.; Narayanan, E.; Liu, Q.; Tsybovsky, Y.; Boswell, K.; Ding, S.; Hu, Z.; Follmann, D.; Lin, Y.; Miao, H. et al.
Source: Self-asserted source
Edward K. Sarfo via Scopus - Elsevier

Altered synaptic ultrastructure in the prefrontal cortex of Shank3-deficient rats

Molecular Autism
2020 | Journal article
DOI: 10.1186/s13229-020-00393-8
EID:

2-s2.0-85096094410

Part of ISSN: 20402392
Contributors: Jacot-Descombes, S.; Keshav, N.U.; Dickstein, D.L.; Wicinski, B.; Janssen, W.G.M.; Hiester, L.L.; Sarfo, E.K.; Warda, T.; Fam, M.M.; Harony-Nicolas, H. et al.
Source: Self-asserted source
Edward K. Sarfo via Scopus - Elsevier

Development of a 3mut-apex-stabilized envelope trimer that expands HIV-1 neutralization breadth when used to boost fusion peptide-directed vaccine-elicited responses

Journal of Virology
2020 | Journal article
DOI: 10.1128/JVI.00074-20
EID:

2-s2.0-85086682801

Part of ISSN: 10985514 0022538X
Contributors: Chuang, G.-Y.; Lai, Y.-T.; Boyington, J.C.; Cheng, C.; Geng, H.; Narpala, S.; Rawi, R.; Schmidt, S.D.; Tsybovsky, Y.; Verardi, R. et al.
Source: Self-asserted source
Edward K. Sarfo via Scopus - Elsevier

Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature

Cell Reports
2020 | Journal article
DOI: 10.1016/j.celrep.2020.107981
EID:

2-s2.0-85088868741

Part of ISSN: 22111247
Contributors: Cheng, C.; Duan, H.; Xu, K.; Chuang, G.-Y.; Corrigan, A.R.; Geng, H.; O'Dell, S.; Ou, L.; Chambers, M.; Changela, A. et al.
Source: Self-asserted source
Edward K. Sarfo via Scopus - Elsevier

Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen

Scientific Reports
2020 | Journal article
DOI: 10.1038/s41598-020-59711-y
EID:

2-s2.0-85079745768

Part of ISSN: 20452322
Contributors: Ou, L.; Kong, W.-P.; Chuang, G.-Y.; Ghosh, M.; Gulla, K.; O’Dell, S.; Varriale, J.; Barefoot, N.; Changela, A.; Chao, C.W. et al.
Source: Self-asserted source
Edward K. Sarfo via Scopus - Elsevier

Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization

Cell
2019 | Journal article
DOI: 10.1016/j.cell.2019.06.030
EID:

2-s2.0-85068975552

Part of ISSN: 10974172 00928674
Contributors: Kong, R.; Duan, H.; Sheng, Z.; Xu, K.; Acharya, P.; Chen, X.; Cheng, C.; Dingens, A.S.; Gorman, J.; Sastry, M. et al.
Source: Self-asserted source
Edward K. Sarfo via Scopus - Elsevier

Consistent elicitation of cross-clade HIV-neutralizing responses achieved in Guinea pigs after fusion peptide priming by repetitive envelope trimer boosting

PLoS ONE
2019 | Journal article
DOI: 10.1371/journal.pone.0215163
EID:

2-s2.0-85064445097

Part of ISSN: 19326203
Contributors: Cheng, C.; Xu, K.; Kong, R.; Chuang, G.-Y.; Corrigan, A.R.; Geng, H.; Hill, K.R.; Jafari, A.J.; O’Dell, S.; Ou, L. et al.
Source: Self-asserted source
Edward K. Sarfo via Scopus - Elsevier

Origins of PDZ Binding Specificity. A Computational and Experimental Study Using NHERF1 and the Parathyroid Hormone Receptor

Biochemistry
2017 | Journal article
DOI: 10.1021/acs.biochem.7b00078
EID:

2-s2.0-85019942831

Part of ISSN: 15204995 00062960
Contributors: Mamonova, T.; Zhang, Q.; Chandra, M.; Collins, B.M.; Sarfo, E.; Bu, Z.; Xiao, K.; Bisello, A.; Friedman, P.A.
Source: Self-asserted source
Edward K. Sarfo via Scopus - Elsevier

Peer review (1 review for 1 publication/grant)

Review activity for PloS one. (1)
How many people are using ORCID?